Puma Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	36.19	29.64	69.22	84.59	76.2	63.13
Short-Term Investments	65.35	67.89	31.75	11.35	4.87	18.98
Cash & Short-Term Investments	101.55	97.53	100.97	95.94	81.07	82.11
Cash Growth	8.99%	-3.40%	5.24%	18.34%	-1.26%	-12.08%
Accounts Receivable	26.33	53.65	32.01	47.84	40.35	32.53
Inventory	8.69	5.52	8.72	7.08	4.53	7.11
Other Current Assets	5.69	5.99	5.96	5.33	8.33	18.28
Total Current Assets	142.26	162.69	147.66	156.19	134.28	140.02
Net Property, Plant & Equipment	4.7	5.56	5.09	8.65	12.51	15.77
Other Intangible Assets	38.96	41.39	51.13	60.87	70.61	66.13
Other Long-Term Assets	6.79	6.66	9.45	4.83	4.66	4.67
Total Assets	192.7	216.3	213.33	230.53	222.06	226.59
Accounts Payable	8.17	5.06	5.51	6.89	6.44	11.17
Accrued Expenses	38.38	50.03	36.9	52.72	65.53	92.58
Current Portion of Long-Term Debt	11.28	22.52	45.33	34	-	-
Current Portion of Leases	0.13	1.31	5.54	4.8	4.14	3.57
Other Current Liabilities	1.79	2.33	2.84	0.98	1.37	2.26
Total Current Liabilities	59.74	81.25	96.11	99.38	77.48	109.59
Long-Term Debt	-	-	21.72	65.66	98.31	97.09
Long-Term Leases	4.55	4.71	1.49	7.03	11.83	15.98
Other Long-Term Liabilities	-	-	1.88	5.01	12.83	6.38
Total Long-Term Liabilities	4.55	4.71	25.1	77.7	122.97	119.45
Total Liabilities	64.28	85.96	121.21	177.09	200.45	229.03
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	1,416	1,414	1,407	1,399	1,388	1,364
Accumulated Other Comprehensive Income	-0.03	0.04	0.01	-0	-	-0
Retained Earnings	-1,288	-1,284	-1,315	-1,345	-1,367	-1,367
Shareholders' Equity	128.42	130.34	92.13	53.44	21.61	-2.45
Total Liabilities & Equity	192.7	216.3	213.33	230.53	222.06	226.59
Total Debt	15.95	28.55	74.08	111.49	114.28	116.64
Net Cash (Debt)	85.59	68.98	26.88	-15.55	-33.21	-34.54
Net Cash Growth	172.12%	156.60%	-	-	-	-
Net Cash Per Share	1.68	1.36	0.55	-0.33	-0.74	-0.85
Book Value	128.42	130.34	92.13	53.44	21.61	-2.45
Book Value Per Share	2.52	2.57	1.88	1.12	0.48	-0.06
Tangible Book Value	89.46	88.95	40.99	-7.43	-49	-68.57
Tangible Book Value Per Share	1.76	1.76	0.83	-0.16	-1.09	-1.69

SEC Filings: 10-K · 10-Q